Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 Mar;225(3):246–251. doi: 10.1097/00000658-199703000-00002

Metabolic responses to interleukin-1: centrally and peripherally mediated.

A G Hill 1, J Siegel 1, J Rounds 1, D W Wilmore 1
PMCID: PMC1190673  PMID: 9060579

Abstract

OBJECTIVE: The purpose of this study was to differentiate between the catabolic effects of interleukin-1 (IL-1) when infused into the central nervous system or into the periphery. SUMMARY BACKGROUND DATA: After injury and infection, IL-1 has been found in the central nervous system. Chronic intracerebrovascular infusion of IL-1 produces protein catabolism, anorexia, and fever. However, IL-1 may act directly on liver and bone marrow to elicit metabolic responses. Although IL-1 is thought to be involved in a number of metabolic responses associated with injury-inflammation, the sites of action are unclear. METHODS: Rats were implanted with chronic infusion pumps and received diluent or three doses of IL-1 infused subcutaneously for 6 days, and a variety of response variables were measured. In a second study, doses were adjusted so that similar systemic catabolic responses were obtained from peripheral and intracerebroventricular infusion of IL-1. The acute-phase responses then were compared in the two groups of animals receiving IL-1 by different routes. RESULT: Subcutaneously infused IL-1 elicited catabolic responses in a dose-response manner. Similar catabolic responses were achieved by infusing one tenth of the dose of IL-1 given subcutaneously into the central nervous system. Although similar systemic responses (protein catabolism, anorexia, fever, and weight loss) were observed with both routes of infusion, the subcutaneous infusion produced a much greater lymphocytosis, elevation in acute-phase reactants, and fall in serum iron and albumin. CONCLUSIONS: The IL-1 appears to have different effects depending on the site of production and site of action. Regionalization of signal proteins such as IL-1 should be taken into consideration when devising specific anticytokine treatment strategies.

Full text

PDF
246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banks W. A., Kastin A. J., Durham D. A. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull. 1989 Dec;23(6):433–437. doi: 10.1016/0361-9230(89)90185-8. [DOI] [PubMed] [Google Scholar]
  2. Friberger P., Sörskog L., Nilsson K., Knös M. The use of a quantitative assay in endotoxin testing. Prog Clin Biol Res. 1987;231:149–169. [PubMed] [Google Scholar]
  3. Gelin J. L., Moldawer L. L., Iresjö B. M., Lundholm K. G. The role of the adrenals in the acute phase response to interleukin-1 and tumor necrosis factor-alpha. J Surg Res. 1993 Jan;54(1):70–78. doi: 10.1006/jsre.1993.1012. [DOI] [PubMed] [Google Scholar]
  4. Hellerstein M. K., Meydani S. N., Meydani M., Wu K., Dinarello C. A. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest. 1989 Jul;84(1):228–235. doi: 10.1172/JCI114145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kampschmidt R. F., Upchurch H. F. Possible involvement of leukocytic endogenous mediator in granulopoiesis. Proc Soc Exp Biol Med. 1977 May;155(1):89–93. doi: 10.3181/00379727-155-39751. [DOI] [PubMed] [Google Scholar]
  6. Klempner M. S., Dinarello C. A., Gallin J. I. Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest. 1978 May;61(5):1330–1336. doi: 10.1172/JCI109050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lang C. H., Cooney R., Vary T. C. Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism. Am J Physiol. 1996 Aug;271(2 Pt 1):E309–E316. doi: 10.1152/ajpendo.1996.271.2.E309. [DOI] [PubMed] [Google Scholar]
  8. Mester M., Carter E. A., Tompkins R. G., Gelfand J. A., Dinarello C. A., Burke J. F., Clark B. D. Thermal injury induces very early production of interleukin-1 alpha in the rat by mechanisms other than endotoxemia. Surgery. 1994 May;115(5):588–596. [PubMed] [Google Scholar]
  9. Michie H. R., Spriggs D. R., Manogue K. R., Sherman M. L., Revhaug A., O'Dwyer S. T., Arthur K., Dinarello C. A., Cerami A., Wolff S. M. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. 1988 Aug;104(2):280–286. [PubMed] [Google Scholar]
  10. Skogerboe K. J., Labbé R. F., Rettmer R. L., Sundquist J. P., Gargett A. M. Chemiluminescent measurement of total urinary nitrogen for accurate calculation of nitrogen balance. Clin Chem. 1990 May;36(5):752–755. [PubMed] [Google Scholar]
  11. Turchik J. B., Bornstein D. L. Role of the central nervous system in acute-phase responses to leukocytic pyrogen. Infect Immun. 1980 Nov;30(2):439–444. doi: 10.1128/iai.30.2.439-444.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Van Snick J. L., Masson P. L., Heremans J. F. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med. 1974 Oct 1;140(4):1068–1084. doi: 10.1084/jem.140.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES